Brean Murray Downgrades Pharmasset to Hold, Removes PT - Verus International (OTC:VRUS) - Benzinga

Brean Murray has downgraded Pharmasset (NASDAQ:

) from Buy to Hold and has removed its $105 price target.

VRUSVerus International Inc

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In:

Downgrades Price Target Analyst Ratings

Comments